Genetic Technologies
GENE
#10486
Rank
โ‚น0.33 B
Marketcap
โ‚น68.72
Share price
0.00%
Change (1 day)
-66.74%
Change (1 year)

Genetic Technologies (GENE) - Cash on Hand

Cash on Hand as of June 2024 : โ‚น61.36 Million

According to Genetic Technologies's latest financial reports the company has โ‚น61.36 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Genetic Technologies - Cash on Hand chart (from 2004 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-06-30โ‚น56.94 M-86.65%
2023-06-30โ‚น0.42 B-33.09%
2022-06-30โ‚น0.63 B-45.43%
2021-06-30โ‚น1.16 B57.86%
2020-06-30โ‚น0.73 B616.99%
2019-06-30โ‚น0.10 B-62.91%
2018-06-30โ‚น0.27 B-49.03%
2017-06-30โ‚น0.54 B-3.2%
2016-06-30โ‚น0.56 B-37%
2015-06-30โ‚น0.89 B459.25%
2014-06-30โ‚น0.16 B52.38%
2013-06-30โ‚น0.10 B-79.28%
2012-06-30โ‚น0.50 B108.2%
2011-06-30โ‚น0.24 B88.64%
2010-06-30โ‚น0.12 B-57.24%
2009-06-30โ‚น0.30 B-45.36%
2008-06-30โ‚น0.55 B20.79%
2007-06-30โ‚น0.45 B24.79%
2006-06-30โ‚น0.36 B-37.45%
2005-06-30โ‚น0.58 B63.49%
2004-06-30โ‚น0.35 B91%
2003-06-30โ‚น0.18 B-4.46%
2002-06-30โ‚น0.19 B1163.26%
2001-06-30โ‚น15.55 M-52.8%
2000-06-30โ‚น32.94 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Eterna Therapeutics
ERNA
โ‚น0.27 B 346.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
โ‚น13.06 B 21,185.54%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚น53.73 B 87,457.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚น38.80 B 63,141.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
โ‚น7.73 B 12,502.68%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Danaher
DHR
โ‚น137.27 B 223,588.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚น318.55 B 519,009.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
โ‚น12.47 B 20,231.49%๐Ÿ‡บ๐Ÿ‡ธ USA